Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Researchers exploring retatrutide for both weight management and glycemic control can find additional protocol details in the timeline to results guide
McGill University Office for Science and Society
Tirzepatide maintenance: the SURMOUNT-4 evidence The SURMOUNT-4 trial used a randomized-withdrawal design: all participants took open-label tirzepatide for 36 weeks (reaching a mean weight reduction of about 20.9%), then were randomized either to continue the drug or switch to placebo for another 52 weeks
Role of Breast Cancer Resistance Protein (BCRP/ABCG2) in Cancer Drug Resistance
Vitamin B12 essential for red blood cell formation and oxygen delivery to scalp
US$ 23.68
US$ 28.50
US$ 27.62
US$ 21.64
US$ 25.36
US$ 24.23
